SPECT con 123I-IBZM: utilidad en el diagnóstico diferencial de parkinsonismos degenerativos y establecimiento de un método de cuantificación

García, V.M. Poblete; Vicente, A. García; Solís, S. Ruíz; Delgado, C. Martínez; Vaamonde, J.; Marina, S. Rodado; Romera, M. Cortés; Rubio, M.P. Talavera; Ibáñez, R.; Castrejón, Á. Soriano

doi:10.1157/13076641

Cited by 5 publications

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Quantification of these studies had limited utility since the overlapping of index values between normal and pathological restricts their use in individual cases [70]. Vlaar et al reported that FP-CIT SPECT is accurate to differentiate patients with IPD from those with ET, and IPD from VP and DIP, but the accuracy of both FP-CIT and IBZM SPECT scans to differentiate between IPD and APS is low [54].…”

Section: The Use Of Spect Molecular Imaging In Pdmentioning

confidence: 99%

SPECT Molecular Imaging in Parkinson's Disease

Wang

Zhang

et al. 2012

Journal of Biomedicine and Biotechnology

View full text Add to dashboard Cite

Parkinson's disease (PD) is a common disorder, and the diagnosis of Parkinson's disease is clinical and relies on the presence of characteristic motor symptoms. The accuracy of the clinical diagnosis of PD is still limited. Functional neuroimaging using SPECT technique is helpful in patients with first signs of parkinsonism. The changes detected may reflect the disease process itself and/or compensatory responses to the disease, or they may arise in association with disease- and/or treatment-related complications. This paper addresses the value of SPECT in early differential diagnosis of PD and its potential as a sensitive tool to assess the pathophysiology and progression, as well as the therapeutic efficacy of PD.

show abstract

Section: The Use Of Spect Molecular Imaging In Pdmentioning

confidence: 99%